OpGen Announces Partial Adjournment of Annual Meeting

NEXT STORY
atai Life Sciences to Present at the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit
PREV STORY
Merus to Participate in William Blair’s Biotech Focus Conference 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OSE Immunotherapeutics Granted Approval to Resume Patient Accrual in U. S. for Phase 3 Tedopi® Clinical Trial in Advanced Non-Small Cell Lung Cancer Patients Following Immune Checkpoint Inhibitor Treatment

NANTES, France, Feb. 27, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE), today announces ...

author_avatar
NASDAQ Market News

Intuitive Surgical Reports New Employee Option Grants for February 2016

SUNNYVALE, Calif., Feb. 09, 2016 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (Nasdaq:ISRG) today reported ...

author_avatar
NASDAQ Market News

Orion and Bayer jointly present new data in prostate cancer from the Darolutamide ARAMIS -study

Orion Corporation                                                        Press Release 5 February 2019 at 3.00 p.m. EET Orion and Bayer ...

author_avatar
NASDAQ Market News